Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ethereum trading volume increases by 41% weekly as funds flow from Bitcoin ETFs to Ethereum funds

Ethereum trading volume increases by 41% weekly as funds flow from Bitcoin ETFs to Ethereum funds

AIcoinAIcoin2026/04/14 04:08
Show original
Ethereum outperformed Bitcoin, with U.S. spot Bitcoin ETFs seeing net outflows exceeding $325 million on April 13, as capital shifted to Ethereum funds, bringing new inflows. Ethereum network activity surged, with weekly daily transaction volume increasing by 41%, but stablecoin transfer volume and fees dropped significantly, indicating a decline in the economic value of on-chain activity. The future trend depends on sustained inflows into Ethereum funds, Bitcoin's ability to absorb ETF outflows, and improvements in the quality of on-chain activity on Ethereum.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

JPMorgan's Q3 adjusted revenue of $50.9 billions misses expectations, fixed income trading revenue unexpectedly drops 4%, US stocks fall over 2% pre-market | Financial Report Insights

JPMorgan's Q3 adjusted revenue amounted to $50.91 billions, falling short of the market expectation of $51.37 billions. Fixed income trading revenue declined by 4% year-on-year, marking its first drop in over two years, while equity trading revenue rose by 49% year-on-year to $4.95 billions, registering the best third-quarter performance on record. Net interest income exceeded expectations, but expenses were higher than anticipated. The bank also posted a net investment securities loss of $658 million.

华尔街见闻•2026/10/13 11:08

Johnson & Johnson (JNJ.US) Q3 profit exceeds expectations and raises full-year guidance! Innovative pharmaceutical business grows, while device business still needs improvement

Johnson & Johnson reported better-than-expected results for the third quarter of 2026 and raised its full-year 2026 revenue and earnings guidance.

智通财经•2026/10/13 10:56